tiprankstipranks
Advertisement
Advertisement
Grail falls -15.6%
PremiumThe FlyGrail falls -15.6%
24d ago
Grail falls -18.4%
Premium
The Fly
Grail falls -18.4%
24d ago
Grail presents ‘positive’ performance, safety results from Pathfinder 2 study
Premium
The Fly
Grail presents ‘positive’ performance, safety results from Pathfinder 2 study
24d ago
Grail price target raised to $69 from $65 at TD Cowen
PremiumThe FlyGrail price target raised to $69 from $65 at TD Cowen
2M ago
Daniel Brennan Reiterates Buy on Strong Galleri Momentum, Clinical Catalysts, and Raises Price Target to $69
Premium
Ratings
Daniel Brennan Reiterates Buy on Strong Galleri Momentum, Clinical Catalysts, and Raises Price Target to $69
2M ago
Grail reports Q1 EPS ($2.29), consensus ($1.96)
Premium
The Fly
Grail reports Q1 EPS ($2.29), consensus ($1.96)
2M ago
Grail price target lowered to $75 from $130 at Guggenheim
PremiumThe FlyGrail price target lowered to $75 from $130 at Guggenheim
3M ago
Block upgraded, Starbucks downgraded: Wall Street’s top analyst calls
Premium
The Fly
Block upgraded, Starbucks downgraded: Wall Street’s top analyst calls
3M ago
Video: Constellation rises as Citi gets more constructive
Premium
The Fly
Video: Constellation rises as Citi gets more constructive
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100